0001179110-18-010585.txt : 20180814
0001179110-18-010585.hdr.sgml : 20180814
20180814173206
ACCESSION NUMBER: 0001179110-18-010585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180810
FILED AS OF DATE: 20180814
DATE AS OF CHANGE: 20180814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Basgoz Nesli
CENTRAL INDEX KEY: 0001361580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36867
FILM NUMBER: 181019060
MAIL ADDRESS:
STREET 1: C/O FOREST LABORATORIES, INC.
STREET 2: 909 THIRD AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allergan plc
CENTRAL INDEX KEY: 0001578845
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
BUSINESS PHONE: (216) 523-5000
MAIL ADDRESS:
STREET 1: CLONSHAUGH BUSINESS AND TECHNOLOGY PARK
CITY: COOLOCK, DUBLIN
STATE: L2
ZIP: D17 E400
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis plc
DATE OF NAME CHANGE: 20130930
FORMER COMPANY:
FORMER CONFORMED NAME: Actavis Ltd
DATE OF NAME CHANGE: 20130607
4
1
edgar.xml
FORM 4 -
X0306
4
2018-08-10
0
0001578845
Allergan plc
AGN
0001361580
Basgoz Nesli
CLONSHAUGH BUSINESS AND TECHNOLOGY PARK,
COOLOCK, CO.
DUBLIN
D17 E400
1
0
0
0
Ordinary Shares, par value $0.0001
2018-08-10
4
M
0
1889
81.16
A
9247.913
D
Ordinary Shares, par value $0.0001
2018-08-10
4
F
0
834
184.00
D
8413.913
D
Non-Qualified Options (Right to buy)
81.16
2018-08-10
4
M
0
1889
0
D
2018-08-11
Ordinary Shares
1889
0
D
Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
These options became vested and exercisable on February 11, 2009.
/s/ A. Robert D. Bailey, Attorney-in-Fact for the Reporting Person
2018-08-14
EX-24
2
ex24basgoz.txt
SECTION 16 POWER OF ATTORNEY
With respect to holdings of and transactions in securities issued by
Allergan plc (the "COMPANY"), the undersigned hereby constitutes and appoints
the individuals named on SCHEDULE A attached hereto and as may be amended from
time to time, or any of them signing singly, with full power of substitution and
resubstitution, to act as the undersigned's true and lawful attorney-in-fact to:
1. prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the United States Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto, and any
other documents necessary or appropriate to obtain and/or regenerate
codes and passwords enabling the undersigned to make electronic filings
with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended, or any rule or regulation of the SEC;
2. execute for and on behalf of the undersigned, Forms 3, 4, and 5 in
accordance with Section 16 of the Securities Exchange Act of 1934, as
amended, and the rules thereunder;
3. do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, or 5, complete and execute any
amendment or amendments thereto, and timely file such form with the
SEC and any stock exchange or similar authority; and
4. take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit to, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in his or her
discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution and
resubstitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorneys-in-fact substitute or substitutes, shall
lawfully do or cause to be done by virtue of this Power of Attorney and the
rights and powers herein granted.
The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is any Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934, as amended.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 10th day of July 2018.
/s/ Nesli Basgoz
----------------------
NAME: Nesli Basgoz
TITLE: Director
SCHEDULE A
Individuals Appointed as Attorney-in-Fact with Full Power of Substitution and
Resubstitution
1. A. Robert D. Bailey, EVP & Chief Legal Officer and Corporate Secretary
2. Matthew Walsh, EVP & Chief Financial Officer
3. James D'Arecca, SVP, Chief Accounting Officer - Global
4. Kira Schwartz, Assistant Secretary